Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Anthony Noto

Deal Dispatch: Abbott, TPG And Lonza Make Major Moves, M&M Custard And New Fortress Energy Struggle

benzinga_deal_dispatch2

New On The Block

  • Swiss life sciences giant Lonza Group is shopping its capsules and health ingredients division, and the shortlist is full of private equity heavy-hitters. In the running: Altaris, Lone Star Funds, and One Rock Capital. Expected sale price: At least €2.5 billion (US$2.8 billion). Think of it as a supplement aisle showdown—except the vitamins cost more than most small countries.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.